Invention Grant
- Patent Title: Neuregulin-4 compounds and methods of use
-
Application No.: US16835787Application Date: 2020-03-31
-
Publication No.: US11242370B2Publication Date: 2022-02-08
- Inventor: Jonathan Wesley Day , Josef George Heuer , Avinash Muppidi , Wei Ni , James David Pancook
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Matthew T. Lord
- Main IPC: C07K14/475
- IPC: C07K14/475 ; A61P9/04 ; A61K38/00 ; A61M5/142

Abstract:
The present invention relates to neuregulin (NRG) 4 compounds and methods of treatment with NRG4 compounds.
Information query